US 8741912
Deazapurines useful as inhibitors of Janus kinases
granted A61PA61P11/06A61P17/06
Quick answer
US patent 8741912 (Deazapurines useful as inhibitors of Janus kinases) held by Vertex Pharmaceuticals Incorporated expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61P, A61P11/06, A61P17/06, A61P17/14, A61P19/02